Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D N Stephens

Showing results (101-110 of 128) with videos related to

Pageof 13
Sort By:
Ultrasonic Imaging|September 15, 2001
Modified weighting method for forward-looking ring-annular arraysJ R Crowe, J D Hamilton, D N Stephens, et al.
Appetite|June 9, 2009
Alpha1- and alpha2-containing GABAA receptor modulation is not necessary for benzodiazepine-induced hyperphagiaH V Morris, S Nilsson, C I Dixon, et al.
Alcoholism, Clinical and Experimental Research|May 17, 2008
Alcohol induces DNA damage and the Fanconi anemia D2 protein implicating FANCD2 in the DNA damage response pathways in brainS L Rulten, E Hodder, T L Ripley, et al.
Journal of Neural Transmission|January 1, 1986
Effect on hypothalamic self-stimulation of the novel beta-carbolines ZK 93 426 (a benzodiazepine receptor antagonist) and ZK 91 296 (a putative partial agonist)L J Herberg, A M Montgomery, S E File, et al.
Psychopharmacology Series|January 1, 1993
Abecarnil: a novel anxiolytic with mixed full agonist/partial agonist properties in animal models of anxiety and sedationD N Stephens, L Turski, G H Jones, et al.
Neuropharmacology|February 1, 1995
Abecarnil enhances GABA-induced currents in acutely isolated cerebellar Purkinje cellsV S Vorobjev, I N Sharonova, V G Skrebitsky, et al.
Advances in Biochemical Psychopharmacology|January 1, 1992
What are the differences between abecarnil and conventional benzodiazepine anxiolytics?D N Stephens, L Turski, M Hillman, et al.
Genes, Brain, and Behavior|April 6, 2006
Sp1 and NFkappaB pathways are regulated in brain in response to acute and chronic ethanolS L Rulten, T L Ripley, C L Hunt, et al.
The European Journal of Neuroscience|May 19, 2006
Both alpha2 and alpha3 GABAA receptor subtypes mediate the anxiolytic properties of benzodiazepine site ligands in the conditioned emotional response paradigmH V Morris, G R Dawson, D S Reynolds, et al.
Brain Research Bulletin|September 1, 1987
Modulation of anxiety by beta-carbolines and other benzodiazepine receptor ligands: relationship of pharmacological to biochemical measures of efficacyD N Stephens, H H Schneider, W Kehr, et al.
Pageof 13

Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Ultrasonic Imaging|September 15, 2001
Modified weighting method for forward-looking ring-annular arraysJ R Crowe, J D Hamilton, D N Stephens, et al.
Appetite|June 9, 2009
Alpha1- and alpha2-containing GABAA receptor modulation is not necessary for benzodiazepine-induced hyperphagiaH V Morris, S Nilsson, C I Dixon, et al.
Alcoholism, Clinical and Experimental Research|May 17, 2008
Alcohol induces DNA damage and the Fanconi anemia D2 protein implicating FANCD2 in the DNA damage response pathways in brainS L Rulten, E Hodder, T L Ripley, et al.
Journal of Neural Transmission|January 1, 1986
Effect on hypothalamic self-stimulation of the novel beta-carbolines ZK 93 426 (a benzodiazepine receptor antagonist) and ZK 91 296 (a putative partial agonist)L J Herberg, A M Montgomery, S E File, et al.
Psychopharmacology Series|January 1, 1993
Abecarnil: a novel anxiolytic with mixed full agonist/partial agonist properties in animal models of anxiety and sedationD N Stephens, L Turski, G H Jones, et al.
Neuropharmacology|February 1, 1995
Abecarnil enhances GABA-induced currents in acutely isolated cerebellar Purkinje cellsV S Vorobjev, I N Sharonova, V G Skrebitsky, et al.
Advances in Biochemical Psychopharmacology|January 1, 1992
What are the differences between abecarnil and conventional benzodiazepine anxiolytics?D N Stephens, L Turski, M Hillman, et al.
Genes, Brain, and Behavior|April 6, 2006
Sp1 and NFkappaB pathways are regulated in brain in response to acute and chronic ethanolS L Rulten, T L Ripley, C L Hunt, et al.
The European Journal of Neuroscience|May 19, 2006
Both alpha2 and alpha3 GABAA receptor subtypes mediate the anxiolytic properties of benzodiazepine site ligands in the conditioned emotional response paradigmH V Morris, G R Dawson, D S Reynolds, et al.
Brain Research Bulletin|September 1, 1987
Modulation of anxiety by beta-carbolines and other benzodiazepine receptor ligands: relationship of pharmacological to biochemical measures of efficacyD N Stephens, H H Schneider, W Kehr, et al.
Pageof 13